USA Non Recurring from 2010 to 2024

USAC Stock  USD 23.99  0.06  0.25%   
USA Compression's Non Recurring is increasing over the years with stable fluctuation. Non Recurring is expected to dwindle to about 3.3 M. During the period from 2010 to 2024 USA Compression Non Recurring annual values regression line had geometric mean of  3,382,580 and mean square error of 28729.7 T. View All Fundamentals
 
Non Recurring  
First Reported
2013-03-31
Previous Quarter
815 K
Current Value
10.6 M
Quarterly Volatility
98.1 M
 
Yuan Drop
 
Covid
Check USA Compression financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USA Compression's main balance sheet or income statement drivers, such as Depreciation And Amortization of 141.4 M, Interest Expense of 178.4 M or Total Revenue of 888.5 M, as well as many indicators such as Price To Sales Ratio of 3.92, Dividend Yield of 0.088 or PTB Ratio of 12.92. USA financial statements analysis is a perfect complement when working with USA Compression Valuation or Volatility modules.
  
Check out the analysis of USA Compression Correlation against competitors.

Latest USA Compression's Non Recurring Growth Pattern

Below is the plot of the Non Recurring of USA Compression Partners over the last few years. It is USA Compression's Non Recurring historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in USA Compression's overall financial position and show how it may be relating to other accounts over time.
Non Recurring10 Years Trend
Pretty Stable
   Non Recurring   
       Timeline  

USA Non Recurring Regression Statistics

Arithmetic Mean58,654,526
Geometric Mean3,382,580
Coefficient Of Variation281.74
Mean Deviation94,501,460
Median3,292,795
Standard Deviation165,253,833
Sample Variance27308.8T
Range627.6M
R-Value0.15
Mean Square Error28729.7T
R-Squared0.02
Significance0.59
Slope5,618,201
Total Sum of Squares382323.6T

USA Non Recurring History

20243.3 M
20233.5 M
2022M
20212.5 M
2020627.6 M
20196.8 M
201821.6 M

About USA Compression Financial Statements

USA Compression stakeholders use historical fundamental indicators, such as USA Compression's Non Recurring, to determine how well the company is positioned to perform in the future. Although USA Compression investors may analyze each financial statement separately, they are all interrelated. For example, changes in USA Compression's assets and liabilities are reflected in the revenues and expenses on USA Compression's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USA Compression Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Recurring3.5 M3.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USA Compression Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USA Compression's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usa Compression Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usa Compression Partners Stock:
Check out the analysis of USA Compression Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USA Compression. If investors know USA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USA Compression listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.44
Dividend Share
2.1
Earnings Share
0.55
Revenue Per Share
8.525
Quarterly Revenue Growth
0.105
The market value of USA Compression Partners is measured differently than its book value, which is the value of USA that is recorded on the company's balance sheet. Investors also form their own opinion of USA Compression's value that differs from its market value or its book value, called intrinsic value, which is USA Compression's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USA Compression's market value can be influenced by many factors that don't directly affect USA Compression's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USA Compression's value and its price as these two are different measures arrived at by different means. Investors typically determine if USA Compression is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USA Compression's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.